Short Bowel Syndrome Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Short Bowel Syndrome Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sale Channel
1.3 Global Short Bowel Syndrome Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Short Bowel Syndrome Drugs Overall Market Size
2.1 Global Short Bowel Syndrome Drugs Market Size: 2021 VS 2027
2.2 Global Short Bowel Syndrome Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Short Bowel Syndrome Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Short Bowel Syndrome Drugs Players in Global Market
3.2 Top Global Short Bowel Syndrome Drugs Companies Ranked by Revenue
3.3 Global Short Bowel Syndrome Drugs Revenue by Companies
3.4 Global Short Bowel Syndrome Drugs Sales by Companies
3.5 Global Short Bowel Syndrome Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Short Bowel Syndrome Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Short Bowel Syndrome Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Short Bowel Syndrome Drugs Players in Global Market
3.8.1 List of Global Tier 1 Short Bowel Syndrome Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Short Bowel Syndrome Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Short Bowel Syndrome Drugs Market Size Markets, 2021 & 2027
4.1.2 Oral Short Bowel Syndrome Drugs
4.1.3 Tablet Short Bowel Syndrome Drugs
4.2 By Type - Global Short Bowel Syndrome Drugs Revenue & Forecasts
4.2.1 By Type - Global Short Bowel Syndrome Drugs Revenue, 2016-2021
4.2.2 By Type - Global Short Bowel Syndrome Drugs Revenue, 2022-2027
4.2.3 By Type - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Short Bowel Syndrome Drugs Sales & Forecasts
4.3.1 By Type - Global Short Bowel Syndrome Drugs Sales, 2016-2021
4.3.2 By Type - Global Short Bowel Syndrome Drugs Sales, 2022-2027
4.3.3 By Type - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Short Bowel Syndrome Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Short Bowel Syndrome Drugs Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Short Bowel Syndrome Drugs Revenue & Forecasts
5.2.1 By Application - Global Short Bowel Syndrome Drugs Revenue, 2016-2021
5.2.2 By Application - Global Short Bowel Syndrome Drugs Revenue, 2022-2027
5.2.3 By Application - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Short Bowel Syndrome Drugs Sales & Forecasts
5.3.1 By Application - Global Short Bowel Syndrome Drugs Sales, 2016-2021
5.3.2 By Application - Global Short Bowel Syndrome Drugs Sales, 2022-2027
5.3.3 By Application - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Short Bowel Syndrome Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Short Bowel Syndrome Drugs Market Size, 2021 & 2027
6.2 By Region - Global Short Bowel Syndrome Drugs Revenue & Forecasts
6.2.1 By Region - Global Short Bowel Syndrome Drugs Revenue, 2016-2021
6.2.2 By Region - Global Short Bowel Syndrome Drugs Revenue, 2022-2027
6.2.3 By Region - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Short Bowel Syndrome Drugs Sales & Forecasts
6.3.1 By Region - Global Short Bowel Syndrome Drugs Sales, 2016-2021
6.3.2 By Region - Global Short Bowel Syndrome Drugs Sales, 2022-2027
6.3.3 By Region - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Short Bowel Syndrome Drugs Revenue, 2016-2027
6.4.2 By Country - North America Short Bowel Syndrome Drugs Sales, 2016-2027
6.4.3 US Short Bowel Syndrome Drugs Market Size, 2016-2027
6.4.4 Canada Short Bowel Syndrome Drugs Market Size, 2016-2027
6.4.5 Mexico Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Short Bowel Syndrome Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Short Bowel Syndrome Drugs Sales, 2016-2027
6.5.3 Germany Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.4 France Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.5 U.K. Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.6 Italy Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.7 Russia Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Short Bowel Syndrome Drugs Market Size, 2016-2027
6.5.9 Benelux Short Bowel Syndrome Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Short Bowel Syndrome Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Short Bowel Syndrome Drugs Sales, 2016-2027
6.6.3 China Short Bowel Syndrome Drugs Market Size, 2016-2027
6.6.4 Japan Short Bowel Syndrome Drugs Market Size, 2016-2027
6.6.5 South Korea Short Bowel Syndrome Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Short Bowel Syndrome Drugs Market Size, 2016-2027
6.6.7 India Short Bowel Syndrome Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Short Bowel Syndrome Drugs Revenue, 2016-2027
6.7.2 By Country - South America Short Bowel Syndrome Drugs Sales, 2016-2027
6.7.3 Brazil Short Bowel Syndrome Drugs Market Size, 2016-2027
6.7.4 Argentina Short Bowel Syndrome Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, 2016-2027
6.8.3 Turkey Short Bowel Syndrome Drugs Market Size, 2016-2027
6.8.4 Israel Short Bowel Syndrome Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Short Bowel Syndrome Drugs Market Size, 2016-2027
6.8.6 UAE Short Bowel Syndrome Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Emmaus Medical
7.1.1 Emmaus Medical Corporate Summary
7.1.2 Emmaus Medical Business Overview
7.1.3 Emmaus Medical Short Bowel Syndrome Drugs Major Product Offerings
7.1.4 Emmaus Medical Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Emmaus Medical Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Short Bowel Syndrome Drugs Major Product Offerings
7.2.4 Merck Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Takeda
7.3.1 Takeda Corporate Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Short Bowel Syndrome Drugs Major Product Offerings
7.3.4 Takeda Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Takeda Key News
7.4 Ardelyx
7.4.1 Ardelyx Corporate Summary
7.4.2 Ardelyx Business Overview
7.4.3 Ardelyx Short Bowel Syndrome Drugs Major Product Offerings
7.4.4 Ardelyx Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Ardelyx Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Major Product Offerings
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Short Bowel Syndrome Drugs Major Product Offerings
7.6.4 Nutrinia Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Short Bowel Syndrome Drugs Major Product Offerings
7.4.4 OxThera Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.7.5 OxThera Key News
7.8 GLyPharma Therapeutic
7.8.1 GLyPharma Therapeutic Corporate Summary
7.8.2 GLyPharma Therapeutic Business Overview
7.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Major Product Offerings
7.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.8.5 GLyPharma Therapeutic Key News
7.9 Sancilio Pharmaceuticals
7.9.1 Sancilio Pharmaceuticals Corporate Summary
7.9.2 Sancilio Pharmaceuticals Business Overview
7.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Major Product Offerings
7.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Sancilio Pharmaceuticals Key News
7.10 Zealand Pharma
7.10.1 Zealand Pharma Corporate Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Short Bowel Syndrome Drugs Major Product Offerings
7.10.4 Zealand Pharma Short Bowel Syndrome Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Zealand Pharma Key News
8 Global Short Bowel Syndrome Drugs Production Capacity, Analysis
8.1 Global Short Bowel Syndrome Drugs Production Capacity, 2016-2027
8.2 Short Bowel Syndrome Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Short Bowel Syndrome Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Short Bowel Syndrome Drugs Supply Chain Analysis
10.1 Short Bowel Syndrome Drugs Industry Value Chain
10.2 Short Bowel Syndrome Drugs Upstream Market
10.3 Short Bowel Syndrome Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Short Bowel Syndrome Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Short Bowel Syndrome Drugs in Global Market
Table 2. Top Short Bowel Syndrome Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Short Bowel Syndrome Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Short Bowel Syndrome Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Short Bowel Syndrome Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Short Bowel Syndrome Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Short Bowel Syndrome Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Short Bowel Syndrome Drugs Product Type
Table 9. List of Global Tier 1 Short Bowel Syndrome Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Short Bowel Syndrome Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2016-2021
Table 15. By Type - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2022-2027
Table 16. By Application - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2016-2021
Table 20. By Application - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2022-2027
Table 21. By Region - Global Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Short Bowel Syndrome Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2016-2021
Table 25. By Region - Global Short Bowel Syndrome Drugs Sales (K Pcs), 2022-2027
Table 26. By Country - North America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Short Bowel Syndrome Drugs Sales, (K Pcs), 2016-2021
Table 29. By Country - North America Short Bowel Syndrome Drugs Sales, (K Pcs), 2022-2027
Table 30. By Country - Europe Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Short Bowel Syndrome Drugs Sales, (K Pcs), 2016-2021
Table 33. By Country - Europe Short Bowel Syndrome Drugs Sales, (K Pcs), 2022-2027
Table 34. By Region - Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Short Bowel Syndrome Drugs Sales, (K Pcs), 2016-2021
Table 37. By Region - Asia Short Bowel Syndrome Drugs Sales, (K Pcs), 2022-2027
Table 38. By Country - South America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Short Bowel Syndrome Drugs Sales, (K Pcs), 2016-2021
Table 41. By Country - South America Short Bowel Syndrome Drugs Sales, (K Pcs), 2022-2027
Table 42. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, (K Pcs), 2016-2021
Table 45. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales, (K Pcs), 2022-2027
Table 46. Emmaus Medical Corporate Summary
Table 47. Emmaus Medical Short Bowel Syndrome Drugs Product Offerings
Table 48. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 49. Merck Corporate Summary
Table 50. Merck Short Bowel Syndrome Drugs Product Offerings
Table 51. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 52. Takeda Corporate Summary
Table 53. Takeda Short Bowel Syndrome Drugs Product Offerings
Table 54. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 55. Ardelyx Corporate Summary
Table 56. Ardelyx Short Bowel Syndrome Drugs Product Offerings
Table 57. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 58. Naia Pharmaceuticals Corporate Summary
Table 59. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Offerings
Table 60. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 61. Nutrinia Corporate Summary
Table 62. Nutrinia Short Bowel Syndrome Drugs Product Offerings
Table 63. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 64. OxThera Corporate Summary
Table 65. OxThera Short Bowel Syndrome Drugs Product Offerings
Table 66. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 67. GLyPharma Therapeutic Corporate Summary
Table 68. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Offerings
Table 69. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 70. Sancilio Pharmaceuticals Corporate Summary
Table 71. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Offerings
Table 72. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 73. Zealand Pharma Corporate Summary
Table 74. Zealand Pharma Short Bowel Syndrome Drugs Product Offerings
Table 75. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2016-2021)
Table 76. Short Bowel Syndrome Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2019-2021 (K Pcs)
Table 77. Global Short Bowel Syndrome Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 78. Global Short Bowel Syndrome Drugs Production by Region, 2016-2021 (K Pcs)
Table 79. Global Short Bowel Syndrome Drugs Production by Region, 2022-2027 (K Pcs)
Table 80. Short Bowel Syndrome Drugs Market Opportunities & Trends in Global Market
Table 81. Short Bowel Syndrome Drugs Market Drivers in Global Market
Table 82. Short Bowel Syndrome Drugs Market Restraints in Global Market
Table 83. Short Bowel Syndrome Drugs Raw Materials
Table 84. Short Bowel Syndrome Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Short Bowel Syndrome Drugs Downstream
Table 86. Short Bowel Syndrome Drugs Downstream Clients in Global Market
Table 87. Short Bowel Syndrome Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Short Bowel Syndrome Drugs Segment by Type
Figure 2. Short Bowel Syndrome Drugs Segment by Application
Figure 3. Global Short Bowel Syndrome Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Short Bowel Syndrome Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Short Bowel Syndrome Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Short Bowel Syndrome Drugs Sales in Global Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Short Bowel Syndrome Drugs Revenue in 2020
Figure 9. By Type - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Short Bowel Syndrome Drugs Price (USD/Pcs), 2016-2027
Figure 12. By Application - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Short Bowel Syndrome Drugs Price (USD/Pcs), 2016-2027
Figure 15. By Region - Global Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 19. US Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 24. Germany Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 33. China Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Short Bowel Syndrome Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Short Bowel Syndrome Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Short Bowel Syndrome Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Short Bowel Syndrome Drugs Production Capacity (K Pcs), 2016-2027
Figure 49. The Percentage of Production Short Bowel Syndrome Drugs by Region, 2020 VS 2027
Figure 50. Short Bowel Syndrome Drugs Industry Value Chain
Figure 51. Marketing Channels

Emmaus Medical
Merck
Takeda
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
GLyPharma Therapeutic
Sancilio Pharmaceuticals
Zealand Pharma